Cargando…

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study

INTRODUCTION: The COVID-19 outbreak has become the dominant issue throughout the world whilst the governments, nations and health services are trying to deal with its impact. The aim of our study is to assess the impact of COVID-19 on patients treated with radical prostatectomy (RP) for prostate can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zattoni, Fabio, Marra, Giancarlo, Kretschmer, Alexander, Preisser, Felix, Tilki, Derya, Kesch, Claudia, Radtke, Jan Philipp, Hoffmann, Nils, Morlacco, Alessandro, Dal Moro, Fabrizio, Soeterik, Timo F.W., van den Bergh, Roderick C.N., Barletta, Francesco, Briganti, Alberto, Montorsi, Francesco, Gandaglia, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Polish Urological Association 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552935/ https://www.ncbi.nlm.nih.gov/pubmed/34729226 http://dx.doi.org/10.5173/ceju.2021.0211

Ejemplares similares

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study
por: Zattoni, F., et al.
Publicado: (2021)

Focal Therapy for Prostate Cancer: Complications and Their Treatment
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis
por: Kesch, Claudia, et al.
Publicado: (2022)

Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
por: Zattoni, Fabio, et al.
Publicado: (2021)

Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives
por: Kretschmer, Alexander, et al.
Publicado: (2021)

Radical Prostatectomy: Sequelae in the Course of Time
por: Kesch, Claudia, et al.
Publicado: (2021)

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
por: Heidegger, Isabel, et al.
Publicado: (2022)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer
por: Bandini, Marco, et al.
Publicado: (2017)

Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer
por: Scuderi, Simone, et al.
Publicado: (2023)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
por: Soeterik, Timo F. W., et al.
Publicado: (2023)

Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?—a narrative review
por: Pellegrino, Antony, et al.
Publicado: (2022)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort
por: Marra, Giancarlo, et al.
Publicado: (2022)

Do prostate cancer-related mobile phone apps have a role in contemporary prostate cancer management? A systematic review by EAU young academic urologists (YAU) urotechnology group
por: Jamnadass, Enakshee, et al.
Publicado: (2020)

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital
por: Paulino Pereira, Leonor J., et al.
Publicado: (2023)

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer
por: Tsaur, Igor, et al.
Publicado: (2021)

Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions
por: Zattoni, Fabio, et al.
Publicado: (2023)

The art of shockwave lithotripsy is an endangered species and is worth saving: the perspective of the European Association of Urology (EAU) Young Academic Urology (YAU) Urolithiasis group
por: Juliebø-Jones, Patrick, et al.
Publicado: (2021)

Comment on ‘Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome’
por: Dell'Oglio, Paolo, et al.
Publicado: (2017)

Effectiveness of endourological management of ureteral stenosis in kidney transplant patients: EAU-YAU kidney transplantation working group collaboration
por: Territo, Angelo, et al.
Publicado: (2023)

Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36: Let’s Not Go Back in Time! What Have We Learned in the Treatment of Localized Prostate Cancer? Applicability of the ENACT Randomized Clinical Trial in Clinical Practice
por: Gómez Rivas, Juan, et al.
Publicado: (2022)

Role of three dimensional (3D) printing in endourology: An update from EAU young academic urologists (YAU) urolithiasis and endourology working group
por: Hameed, B. M. Zeeshan, et al.
Publicado: (2022)

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer
por: Bravi, Carlo A., et al.
Publicado: (2022)

Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy
por: Bandini, Marco, et al.
Publicado: (2018)

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
por: Preisser, Felix, et al.
Publicado: (2018)

Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms
por: Preisser, Felix, et al.
Publicado: (2022)

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
por: Preisser, Felix, et al.
Publicado: (2021)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
por: Drago, Denise, et al.
Publicado: (2021)

Non-prostatic pathology on prostate needle-biopsy – colorectal carcinoid: a case report
por: van den Bergh, Roderick CN, et al.
Publicado: (2009)

Updates in prostate cancer detections and treatments – Messages from 2017 EAU and AUA()
por: Xie, Liping, et al.
Publicado: (2018)

Expression-profiling of apoptosis induced by ablation of the long ncRNA TRPM2-AS in prostate cancer cell
por: Lavorgna, Giovanni, et al.
Publicado: (2014)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
por: Heetman, Joris G., et al.
Publicado: (2022)

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023)

Metabolic Syndrome and Benign Prostatic Hyperplasia: Evidence of a Potential Relationship, Hypothesized Etiology, and Prevention
por: Abdollah, Firas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kc5galbvjcbo70plqe93sjibkg